The Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The market value is evaluated at ex-factory prices.
- Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.
- Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.
- Note that any volumes of "1" (one) or 100% are due to rounding as the publisher does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.
- All market data and forecasts are represented in nominal terms (i.e., without adjustment for inflation) and all currency conversions used in the creation of this report have been calculated using constant 2020 annual average exchange rates.
- Forecast figures presented in this report are calculated using crisis scenarios for the market. The length of the pandemic and restrictions introduced by various countries are still difficult to predict. Many governments had introduced the national lockdowns and temporarily banned sales of products that are deemed "non-essential". As the length of the pandemic and its impact on this market is not certain, the data used in this report has been modeled taking forecast impacts on national economics into consideration.
- The global generics market had total revenues of $348.3bn in 2020, representing a compound annual growth rate (CAGR) of 5.1% between 2016 and 2020.
- Market consumption volume increased with a CAGR of 2.2% between 2016 and 2020, to reach a total of 68.0% in 2020.
- Historically, growth has been strongest in the Asia-Pacific and European regions and has been moderate in the US.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the global generics market by value in 2020?
- What will be the size of the global generics market in 2025?
- What factors are affecting the strength of competition in the global generics market?
- How has the market performed over the last five years?
- How large is the global generics market in relation to its regional counterparts?
Table of Contents
1 Executive Summary1.1. Market value1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Competitive Landscape
2 Introduction2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions
3 Global Generics3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators
4 Generics in Asia-Pacific4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
5 Generics in Europe5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators
6 Generics in France6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators
7 Generics in Germany7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
7.6. Macroeconomic Indicators
8 Generics in Italy8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
8.6. Macroeconomic Indicators
9 Generics in Japan9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
9.6. Macroeconomic Indicators
10 Generics in Australia10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
10.6. Macroeconomic Indicators
11 Generics in Canada11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
11.6. Macroeconomic Indicators
12 Generics in China12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis
12.6. Macroeconomic Indicators
13 Generics in The Netherlands13.1. Market Overview
13.2. Market Data
13.3. Market Segmentation
13.4. Market outlook
13.5. Five forces analysis
13.6. Macroeconomic Indicators
14 Generics in Spain14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis
14.6. Macroeconomic Indicators
15 Generics in The United Kingdom15.1. Market Overview
15.2. Market Data
15.3. Market Segmentation
15.4. Market outlook
15.5. Five forces analysis
15.6. Macroeconomic Indicators
16 Generics in The United States16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis
16.6. Macroeconomic Indicators
17 Company Profiles17.1. Sun Pharmaceutical Industries Ltd
17.2. Les Laboratoires Servier
17.3. STADA Arzneimittel AG
17.4. Daiichi Sankyo Co Ltd
17.5. Sawai Pharmaceutical Co Ltd
17.6. Aspen Pharmacare Holdings Ltd
17.7. Lupin Ltd
17.8. Apotex, Inc.
17.9. China Grand Pharmaceutical and Healthcare Holdings Limited
17.10. Sanofi SA
17.11. Esteve Group
17.12. Viatris Inc.
17.13. Teva Pharmaceutical Industries Limited
17.14. Pfizer Inc.
18 Appendix18.1. Methodology
18.2. About the publisher
List of TablesTable 1: Global generics market value: $ billion, 2016-20
Table 2: Global generics market volume: %, 2016-20
Table 3: Global generics market geography segmentation: $ billion, 2020
Table 4: Global generics market value forecast: $ billion, 2020-25
Table 5: Global generics market volume forecast: %, 2020-25
Table 6: Global size of population (million), 2016-20
Table 7: Global GDP (constant 2005 prices, $ billion), 2016-20
Table 8: Global GDP (current prices, $ billion), 2016-20
Table 9: Global inflation, 2016-20
Table 10: Global consumer price index (absolute), 2016-20
Table 11: Global exchange rate, 2016-20
Table 12: Asia-Pacific generics market value: $ billion, 2016-20
Table 13: Asia-Pacific generics market volume: %, 2016-20
Table 14: Asia-Pacific generics market geography segmentation: $ billion, 2020
Table 15: Asia-Pacific generics market value forecast: $ billion, 2020-25
Table 16: Asia-Pacific generics market volume forecast: %, 2020-25
Table 17: Europe generics market value: $ billion, 2016-20
Table 18: Europe generics market volume: %, 2016-20
Table 19: Europe generics market geography segmentation: $ billion, 2020
Table 20: Europe generics market value forecast: $ billion, 2020-25
Table 21: Europe generics market volume forecast: %, 2020-25
Table 22: Europe size of population (million), 2016-20
Table 23: Europe GDP (constant 2005 prices, $ billion), 2016-20
Table 24: Europe GDP (current prices, $ billion), 2016-20
Table 25: Europe inflation, 2016-20
Table 26: Europe consumer price index (absolute), 2016-20
Table 27: Europe exchange rate, 2016-20
Table 28: France generics market value: $ million, 2016-20
Table 29: France generics market volume: %, 2016-20
Table 30: France generics market geography segmentation: $ million, 2020
Table 31: France generics market value forecast: $ million, 2020-25
Table 32: France generics market volume forecast: %, 2020-25
Table 33: France size of population (million), 2016-20
Table 34: France GDP (constant 2005 prices, $ billion), 2016-20
Table 35: France GDP (current prices, $ billion), 2016-20
Table 36: France inflation, 2016-20
Table 37: France consumer price index (absolute), 2016-20
Table 38: France exchange rate, 2016-20
Table 39: Germany generics market value: $ billion, 2016-20
Table 40: Germany generics market volume: %, 2016-20
Table 41: Germany generics market geography segmentation: $ billion, 2020
Table 42: Germany generics market value forecast: $ billion, 2020-25
Table 43: Germany generics market volume forecast: %, 2020-25
Table 44: Germany size of population (million), 2016-20
Table 45: Germany GDP (constant 2005 prices, $ billion), 2016-20
Table 46: Germany GDP (current prices, $ billion), 2016-20
Table 47: Germany inflation, 2016-20
Table 48: Germany consumer price index (absolute), 2016-20
Table 49: Germany exchange rate, 2016-20
Table 50: Italy generics market value: $ million, 2016-20
Table 51: Italy generics market volume: %, 2016-20
Table 52: Italy generics market geography segmentation: $ million, 2020
Table 53: Italy generics market value forecast: $ million, 2020-25
Table 54: Italy generics market volume forecast: %, 2020-25
Table 55: Italy size of population (million), 2016-20
Table 56: Italy GDP (constant 2005 prices, $ billion), 2016-20
Table 57: Italy GDP (current prices, $ billion), 2016-20
Table 58: Italy inflation, 2016-20
Table 59: Italy consumer price index (absolute), 2016-20
Table 60: Italy exchange rate, 2016-20
Table 61: Japan generics market value: $ billion, 2016-20
Table 62: Japan generics market volume: %, 2016-20
Table 63: Japan generics market geography segmentation: $ billion, 2020
Table 64: Japan generics market value forecast: $ billion, 2020-25
Table 65: Japan generics market volume forecast: %, 2020-25
List of FiguresFigure 1: Global generics market value: $ billion, 2016-20
Figure 2: Global generics market volume: %, 2016-20
Figure 3: Global generics market geography segmentation: % share, by value, 2020
Figure 4: Global generics market value forecast: $ billion, 2020-25
Figure 5: Global generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the global generics market, 2020
Figure 7: Drivers of buyer power in the global generics market, 2020
Figure 8: Drivers of supplier power in the global generics market, 2020
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2020
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2020
Figure 11: Drivers of degree of rivalry in the global generics market, 2020
Figure 12: Asia-Pacific generics market value: $ billion, 2016-20
Figure 13: Asia-Pacific generics market volume: %, 2016-20
Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2020
Figure 15: Asia-Pacific generics market value forecast: $ billion, 2020-25
Figure 16: Asia-Pacific generics market volume forecast: %, 2020-25
Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2020
Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2020
Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2020
Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2020
Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2020
Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2020
Figure 23: Europe generics market value: $ billion, 2016-20
Figure 24: Europe generics market volume: %, 2016-20
Figure 25: Europe generics market geography segmentation: % share, by value, 2020
Figure 26: Europe generics market value forecast: $ billion, 2020-25
Figure 27: Europe generics market volume forecast: %, 2020-25
Figure 28: Forces driving competition in the generics market in Europe, 2020
Figure 29: Drivers of buyer power in the generics market in Europe, 2020
Figure 30: Drivers of supplier power in the generics market in Europe, 2020
Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2020
Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2020
Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2020
Figure 34: France generics market value: $ million, 2016-20
Figure 35: France generics market volume: %, 2016-20
Figure 36: France generics market geography segmentation: % share, by value, 2020
Figure 37: France generics market value forecast: $ million, 2020-25
Figure 38: France generics market volume forecast: %, 2020-25
Figure 39: Forces driving competition in the generics market in France, 2020
Figure 40: Drivers of buyer power in the generics market in France, 2020
Figure 41: Drivers of supplier power in the generics market in France, 2020
Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2020
Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2020
Figure 44: Drivers of degree of rivalry in the generics market in France, 2020
Figure 45: Germany generics market value: $ billion, 2016-20
Figure 46: Germany generics market volume: %, 2016-20
Figure 47: Germany generics market geography segmentation: % share, by value, 2020
Figure 48: Germany generics market value forecast: $ billion, 2020-25
Figure 49: Germany generics market volume forecast: %, 2020-25
Figure 50: Forces driving competition in the generics market in Germany, 2020
Figure 51: Drivers of buyer power in the generics market in Germany, 2020
Figure 52: Drivers of supplier power in the generics market in Germany, 2020
Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2020
Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2020
Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2020
Figure 56: Italy generics market value: $ million, 2016-20
Figure 57: Italy generics market volume: %, 2016-20
Figure 58: Italy generics market geography segmentation: % share, by value, 2020
Figure 59: Italy generics market value forecast: $ million, 2020-25
Figure 60: Italy generics market volume forecast: %, 2020-25
Figure 61: Forces driving competition in the generics market in Italy, 2020
Figure 62: Drivers of buyer power in the generics market in Italy, 2020
Figure 63: Drivers of supplier power in the generics market in Italy, 2020
Figure 64: Factors influencing the likelihood of new entrants in the generics market in Italy, 2020
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Sun Pharmaceutical Industries Ltd
- Les Laboratoires Servier
- STADA Arzneimittel AG
- Daiichi Sankyo Co Ltd
- Sawai Pharmaceutical Co Ltd
- Aspen Pharmacare Holdings Ltd
- Lupin Ltd
- Apotex, Inc.
- China Grand Pharmaceutical and Healthcare Holdings Limited
- Sanofi SA
- Esteve Group
- Viatris Inc.
- Teva Pharmaceutical Industries Limited
- Pfizer Inc.
